2010 Trends to Watch: Pharmaceutical Technology

Introduction

In collaboration with analysts from Datamonitor's Healthcare business unit, in this brief Ovum's Pharmaceutical Technology team outlines the key changes in the pharma industry, explains which trends will have the biggest impact, and analyses the implications and opportunities of these developments for both pharmaceutical companies and providers of technologies and services.

Scope

• This brief outlines business issues and technology enablers that are expected to affect the pharmaceutical industry during 2010.
• The report covers developments in North America and Europe.

Highlights

Through research and analysis, Ovum has identified several key trends that will shape the pharma and biotech markets in 2010. Pharma is evolving towards a new business model: Pharma 2.0, new R&D models embrace biotechnology and biomedical research and the future success of pharma relies on the emerging markets.

As the life sciences industry moves into its next phase, technology will play a significant role in its transformation. However, in the short term, there will be some solutions that will take precedence over others.

Reasons to Purchase

• Understand the key operational trends to watch during 2010.
• Gain insight into the technologies that pharmaceutical companies must either invest in or extract more value from in 2010.